Century Therapeutics Inc

NASDAQ:IPSC  
15.23
-0.43 (-2.75%)
Earnings Announcements

Century Therapeutics Reports Q3 2021 Financial Results

Published: 11/10/2021 12:39 GMT
Century Therapeutics Inc (IPSC) - Century Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates.
Qtrly Net Loss per Common Share, Basic and Diluted $0.48.
Q3 Earnings per Share View $-0.40 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.48

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.46

More details on our Analysts Page.